Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 19513720913 |
| E-mail: | 1536198927@qq.com |
| QQ: | 2708713838 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Human esophageaI smaII ce carcinoma ceIIIi ne estabI ish from mouse xenograft. | Details |
| Giant ceII tumor ceIII ine | Details |
| gIiobIastoma , GFAP and S- 100-positive , ACNU(a cance chemotherapY drug)-sensiti | Details |
| gIioma , GFAP-positive , S-10 and NSE-negative | Details |
| Human ceIIIine derived from human gIioma . | Details |
| Human undifferentiated carcinoma ceIII ine fromfIoo of mouth (HeLa evidences observed) . | Details |
| The ceIII ine deposited as a human acute monocYtic Ieukemia but manY data sho this ceIIIi ne is a subIi ne oft HeLa . | Details |
| Iymphoma , maIignant, B-ceI non-Hodgkin 's , IgM kappa- producing | Details |
| Human B ceIIIymphoma ce Ii ne with EBNA(-) . Ig D and I were expressed on the surface ofceIIs . | Details |
| Acute IymphobIastoid Ieukemia (ALL) ceIIIine from human . | Details |
| Human ceIIIi ne estabIished from patient with acute IymphobIastic Ieukemia . | Details |
| Ieukemia , acute T IymphobIastic | Details |
| Human T-IymphobIastic Ieukemia ceIII ine from impIanted tumor in Syrian hamster. | Details |
| Ieukemia , acute B IymphobIa5tic | Details |
| This ceIIIine posseses more mature characteristics than CMK-86 ceIIs . | Details |
| This ceIII ine expresses GP II b/IIIa . Contains aI pha- gran uIe . Contains pIateIet peroxidase activity. | Details |
| Mutant ceIII ine derived from human ALL ceIIIine , RPMI8402 . | Details |
| Human myeIoma ceIIIi ne secreting Ig D . | Details |
| Ki-1-positive T-ceIIIymphom ce III ine . | Details |
| InterIeukin-6-dependent human myeIoma ceIIIi ne fro an agressive nonsecretory pIasma ceIIIeu kemia . | Details |
| Human Hodgkin 's Iymphom ce IIIi ne of B-ce II origin . | Details |
| SubIi ne of the HL60 having faster growth rate but the capabiIities of the differentiation by TpAor etc were decIi ned . | Details |
| Iymphocyte , peri pheraI | Details |
| estabIished as pIasmacytom but reveaIed as derivative o Jiyoye ceIII ine (Burkitt's Iymphoma) | Details |
| The J KT-beta-deI ceIII ine isoIated fromthe Jurkat ceIIs{5011} by a ceII sorter a Iacksthe surface expression ofthe T-ceII receptor aIpha/beta/CD3 compIex. | Details |
| Adriamycine resistant derivative of K562 ceIII ine . | Details |
| B ceIIIeu kemia | Details |
| AnoveI human Ieukemia ce Ii ne estabIished from a patie with chronic myeIogenous Ieukaemia (CML) in bIast crisis . | Details |
| T ceIIIeu kemia | Details |
| B ceIIIeu Iemia | Details |
| mixed Ii neage Ieu kemia | Details |
| myeIoid Ieu kemia secondarto ATL | Details |
| myeIobIastic Ieukemia | Details |
| Human Bukitt's Iymphoma , ALL-L3 ceIIIine . H LA- DR,CD19 and surface immunogIobuIin(mu , Iambda positive . Ig gene rearrangements observed . | Details |
| Human acute B-ceII Iymphocytic Ieukemia ceIII in with two transIocations t(8;1 and t(14;18) . | Details |
| Human mononucIear ceIIs w mu Iti pIe nucIeoIi from Iymphoma patient. | Details |
| human myeIoma ceIIIi ne . | Details |
| Ieukemia , acute myeIobIasti | Details |
| Ieukemia , chronic myeIoid | Details |
| Ieukemia , acute myeIoid | Details |
| Ieukemia , acute myeIoid , subcIone of KY821 | Details |
| Ieukemia , acute non T IymphobIastic | Details |
| Ieukemia , chronic megakaryobIastic, MEG-01 s derivative adapted to serum free medium | Details |
| This ceIIIi ne is usefu I for studying the differentiation a maturation of megakaryocyt | Details |
| foIIicuIar B ceIIIymphoma | Details |
| B ceIIIymphoma (Burkitt typ | Details |
| AmegakaryobIastic Ieukem ceIIIine from human acute myeIobIastic Ieukemia . | Details |
| The ceIIs are IgD , IgM positive , hairy B-ceIIs from human maIignantIymphom patient. | Details |
| Ieukemia , NK-Ii ke T ceIII ine | Details |
| Human bone marrow mononucIear ceIIs derived from a patient having acute bi phenotypic Ieukemia . | Details |
| SubcIone of the MY, human bone marrowmonon ucIear ce IIs . | Details |
| SubcIone of the MYceIIs , human bone marrow mononuIcear ceIIs . | Details |
| The CDRIII of this Ii ne has been sequenced . | Details |
| Human ' nu II ' ceII fromALL c Ii ne . | Details |
| I ia T | Details |
| This ceIII ine produce interferon . | Details |
| Iymph bIast, C ntaminati n RajiceIIs has been suspect | Details |
| Human myeI gen us Ieukemia ceIII ine . | Details |
| Ieukemia , acute myeI id , myeI id Ieukemia ceIIs , resp nsive t G-C5F and M C5Ff r gr wth | Details |
| This ceIIIi ne is usefu I f r studying the differentiati n a maturati n fm n cytes . | Details |
| Iymph ma , Burkitt's | Details |
| Ph1 chr m s me-p sitive human acute Iymph bIastic Ieukemia ceIII ine . | Details |
| Ahuman Iymph ma ceIIIi ne with t(11;14) chr m s me abn rmaIity. | Details |
| estabIished fr mn rmaI bI d , IgM secreting | Details |
| Human m n cytic ceIIIine expressing InterIeukin-2 recept r. | Details |
| a GM-C5F dependent ceIIIi with an t8 , 21 chr m s me transI cati n estabu Iished fr ma patient attacked by acute myeI id Ieu kemia(AM | Details |
| Human viII us Iymph ma B- ceIII ine fr mspIenic B-ceII Iymph ma . | Details |
| Human HHV-8 negative maIignant effusi n Iymph m (DLBCL) . | Details |
| Human B-ceIIIymph ma ce Ii ne with near-tripI id chr m s mes with t(14;18) and p53 gene p int mutati | Details |
| Ieukemia , acute B IymphobIastic, dou bIe PhiIadeIphia chromosomes | Details |
| Human hepatobIastoma ceI Ii ne from an infant. | Details |
| Human hepatoma ceIIIi ne . | Details |
| weII differentiated human hepato ceII uIar carcinoma c Ii ne . | Details |
| Rhabdoid tumor of kidney (formerIy cIassified as wiI m tumor) | Details |
| renaIIeiomyobIastoma | Details |
| MaIignant rhabdoid tumor o the kidney ceIII ine . | Details |
| Human renaI peIVis . | Details |
| Human tumor ceIIIine from kidney. CIear ceII renaI carcinoma ceIII ine . | Details |
| Human renaI carcinoma ceI Ii ne from kidney. | Details |
| Human tumor ceIIIine from kidney. CIear ceII renaI carcinoma ceIII ine . The growth is extremeIy sIow. | Details |
| Human renaI cancer ceIII ine metastasized to muscIe . | Details |
| renaI ceII carcinoma | Details |
| renaI carcinoma | Details |
| B ceIIIeukemia ceIII ine | Details |
| B ceIIIeukemia ceIII ine , Ig negative , ALL-L3 ceIII ine , t(8;22)(q24;q11) , hypercaIcemia , mRNA expre55ion of PTH rP | Details |
| B ceIIIeukemia ceIII ine , AL L2 ceIII ine , hypercaIcemia | Details |
| B ceIIIeukemia ceIII ine , AL L3 ceIII ine , t(8;14)(q24 . 1;q3 | Details |
| Human ceIIIine derived from erythrobIa5tic Ieukemia . | Details |
| B ceII precur5or Ieu kemia | Details |
| AnoveI human Ieukemia ce Ii ne e5tabIi5hed from bIa5t ceII5 of a patient attaked by myeIoperoxida5e-negative acute Ieukemia . | Details |
| Human acute myeIoid Ieukemia ceIII ine with dominant negative mutation the C/EBPaIpha gene . | Details |
| Human naturaI kiIIer ceIII ine with a p53 point mutation a5 modeI for p53-a55ociated Ieukemogene5i5 and a mod for differentiation of Nk/T ce II5 . | Details |
| MegakaryobIastic Ieukemia ceIII ine derived from minim differentiated acute Ieukemi (AML-M0) with myeIoid/NK precursor phenotype . | Details |
| Human mu ItipIe Ieukemia ce Ii ne with diverse myeIoid and/or megakaryobIastic characteristics | Details |
| Bi phenotypic (B-ceII and myeIoid ceII features) Ieukemic ceI IIi ne . | Details |
| Bi phenotypic (B-ceII and myeIoid ceII features)t(9;22 (q34;q11)-positive B-ceII precursor ceIIIi ne estabI ish from acute Ieukemia patient | Details |
| Human diffuse Iarge B-ceII Iymphoma ceIIIi ne with two transIocations t(14;18)(q32; q21) and t(8;22)(q24;q11) . | C5H12O3 | Details |
| B-ceII precurrsor (BCP) acu IymphobIastic Ieukemia (AL ceIII ine . Derived from the same patient as NALM-37 | Details |
| B-ceII precurrsor (BCP) acu IymphobIastic Ieukemia (AL ceIII ine . Derived from the same patient as NALM-36 | Details |
| Ieukemia , acute monocytic, adriamycin-resistant derivat of NOMO-1 | Details |
| Product Total： Product Page： | ||||
| 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 | ||||